Law360, New York (February 03, 2010, 5:50 PM ET) -- Medical device maker AtriCure Inc. has reached a $3.76 million settlement with the U.S. Department of Justice, putting to rest claims that the company improperly marketed devices used to treat abnormal heart rhythms and enticed physicians and hospitals to inflate Medicare costs related to their use.
The agreement resolves allegations raised in a DOJ investigation and a related whistleblower case in the U.S. District Court for the Southern District of Texas that AtriCure marketed its surgical ablation systems used to treat atrial fibrillation, a common type...
AtriCure Settles Medicare Fraud Claims For $3.8M
To view the full article, take a free trial now.
